Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
ID: PAR-22-163 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 4/19/22 the National Institutes of Health posted grant opportunity PAR-22-163 for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional).
The grant will be issued under grant program 93.859 Biomedical Research and Research Training.
Timing
Posted Date
April 19, 2022, 12:00 a.m. EDT
Closing Date
Sept. 27, 2022, 12:00 a.m. EDT Past Due
Last Updated
April 19, 2022, 3:03 p.m. EDT
Version
1
Archive Date
Nov. 2, 2022
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See Full Announcement for additional Eligibility Details
Award Sizing
Ceiling
$1,500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information Site